LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of ...

On a humid April afternoon, Christine Gala picked her way through the wreckage of what used to be Trico Shrimping Company, before Hurricane Ian had its way with it. She made her way to the western ...

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient. Ac-225 ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. This publication includes existing experiences, lessons ...

A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. JNJ-6420 exposure and clinical activity.

LANSING, Mich., June 7, 2024 /CNW/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and ...

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient. Ac-225 is ...